2,4-Dibromo-1,3-thiazole → tert-Butyl [3-(4-bromo-1,3-thiazol-2-yl)-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl]acetate
反応式
[O:1]=[C:2]1[N:6]([CH2:7][C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9])[C:5]2[CH:15]=[CH:16][CH:17]=[CH:18][C:4]=2[NH:3]1.Br[C:20]1[S:21][CH:22]=[C:23]([Br:25])[N:24]=1>>[Br:25][C:23]1[N:24]=[C:20]([N:3]2[C:4]3[CH:18]=[CH:17][CH:16]=[CH:15][C:5]=3[N:6]([CH2:7][C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9])[C:2]2=[O:1])[S:21][CH:22]=1参加物
3
実験手順
Essentially following the procedures described for Intermediate 4, but using 2,4-dibromothiazole in place of 2-bromopyridine, the title compound was prepared. MS: m/z=412 (M+1).
出典と根拠
- ORDレコード
- ord-2a9da5bcf3814d98aafd4580e409c18c
- 出典データセット
- uspto-grants-2007_04
- 特許番号
- US07202251B2
反応ノート
読み込み中…